Buffered Hypochlorite based Technology – The Innovation

Buffered Hypochlorite based Technology form the core of RLS Global’s operations and are the basis of all the company’s products.

The unique benefits of these solutions include:

  • Softening damaged or dead tissue, making it easier to remove – a gentle approach to save healthy tissue
  • Working without having an effect on healthy tissue

The technological platform is effective for treating caries and for assisting mechanical debridement as part of treating inflammation around teeth and implants. Early on, RLS Global launched oral care products using its technological platform. The company has over 20 years’ experience of research into Buffered Hypochlorite based Technology and develops products that do not affect healthy tissue, which is uncommon for these types of treatments.

The products have been used within oral care since the nineties without any documented side effects. A total of over 160 clinical studies have been published about the platform on Pubmed. Based on our experience from removing de-vitalized tissue for caries removal we are now developing a new innovative solution for hard to heal wounds in need of debridement. Hard to heal wounds that are difficult to heal is a serious and costly complication of underlying diseases such as diabetes, venous insufficiency or injuries to the skin such as pressure ulcers. Patients suffering from these wounds often experience pain, bad smell, decreased mobility and other problems which seriously affecting the quality of life.

Our overall goal is to provide a gentle and effective debridement method that result in improved wound care for healthcare professionals reducing the suffering for patients and the overall cost for the society in treating complicated wounds.

ChloraSolv

RLS Global develops a Gentle method for debridement of hard to heal wounds based on our unique Buffered Hypochlorite Technology Platform.

The Product